Edesa Biotech Extends Dermatitis Study to Canada

Go back to Edesa Biotech Extends Dermatitis Study to Canada
(NASDAQ: EDSA) Delayed: 4.57 -0.09 (1.93%)
Previous Close $4.66    52 Week High
Open $4.70    52 Week Low
Day High $4.84    P/E N/A 
Day Low $4.55    EPS
Volume 8,647